Literature DB >> 25307772

Kaposiform lymphangiomatosis: unifying features of a heterogeneous disorder.

Violet M Fernandes1, John H Fargo, Surbhi Saini, Michael F Guerrera, Leigh Marcus, Lori Luchtman-Jones, Denise Adams, Emily Riehm Meier.   

Abstract

Kaposiform lymphangiomatosis (KLA) is a rare proliferation of abnormal lymphatic vessels often complicated by pleural/pericardial effusions and a consumptive coagulopathy that may lead to life threatening hemorrhage. Establishing the diagnosis is challenging due to the clinical heterogeneity and variable findings in laboratory values, radiographic features, and pathologic characteristics. We report three patients who had slowly progressive symptoms and presented with pleural or pericardial effusions, evidence of a consumptive coagulopathy and anemia. Despite being a rare and challenging diagnosis, KLA should be considered in patients presenting with non-specific indolent symptoms, pleural or pericardial effusions and laboratory evidence of a consumptive coagulopathy.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  GLA; KLA; consumptive coagulopathy; kaposiform lymphangiomatosis; pericardial effusion; pleural effusion

Mesh:

Year:  2014        PMID: 25307772     DOI: 10.1002/pbc.25278

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  8 in total

1.  Pseudotumor cerebri in kaposiform lymphangiomatosis: a case report and pathogenetic hypothesis.

Authors:  Cristina Barceló-López; Antonio L López-Guerrero; Antonio García-López; José Hurtado-Marín; Helena Alarcón-Martínez; Juan F Martínez-Lage
Journal:  Childs Nerv Syst       Date:  2018-04-13       Impact factor: 1.475

2.  Imaging features of kaposiform lymphangiomatosis.

Authors:  Pradeep Goyal; Ahmad I Alomari; Harry P Kozakewich; Cameron C Trenor; Antonio R Perez-Atayde; Steven J Fishman; Arin K Greene; Raja Shaikh; Gulraiz Chaudry
Journal:  Pediatr Radiol       Date:  2016-04-06

3.  Signaling pathways and inhibitors of cells from patients with kaposiform lymphangiomatosis.

Authors:  Elisa Boscolo; Patricia Pastura; Kathryn Glaser; Jillian Goines; Adrienne M Hammill; Denise M Adams; Peter Dickie; Belinda Hsi Dickie; Timothy D Le Cras
Journal:  Pediatr Blood Cancer       Date:  2019-05-02       Impact factor: 3.167

4.  Kaposiform hemangioendothelioma without cutaneous involvement.

Authors:  Yi Ji; Siyuan Chen; Lizhi Li; Kaiying Yang; Chunchao Xia; Li Li; Gang Yang; Feiteng Kong; Guoyan Lu; Xingtao Liu
Journal:  J Cancer Res Clin Oncol       Date:  2018-10-06       Impact factor: 4.553

5.  Sirolimus in the treatment of kaposiform lymphangiomatosis.

Authors:  Jiangyuan Zhou; Kaiying Yang; Siyuan Chen; Yi Ji
Journal:  Orphanet J Rare Dis       Date:  2021-06-08       Impact factor: 4.123

6.  A somatic activating NRAS variant associated with kaposiform lymphangiomatosis.

Authors:  Sarah F Barclay; Kyle W Inman; Valerie L Luks; John B McIntyre; Alyaa Al-Ibraheemi; Alanna J Church; Antonio R Perez-Atayde; Shamlal Mangray; Michael Jeng; Sara R Kreimer; Lori Walker; Steven J Fishman; Ahmad I Alomari; Gulraiz Chaudry; Cameron C Trenor Iii; Denise Adams; Harry P W Kozakewich; Kyle C Kurek
Journal:  Genet Med       Date:  2018-12-13       Impact factor: 8.822

7.  Kaposiform lymphangiomatosis and kaposiform hemangioendothelioma: similarities and differences.

Authors:  Yi Ji; Siyuan Chen; Suhua Peng; Chunchao Xia; Li Li
Journal:  Orphanet J Rare Dis       Date:  2019-07-05       Impact factor: 4.123

8.  CT and MRI Findings of Focal Splenic Lesions and Ascites in Generalized Lymphatic Anomaly, Kaposiform Lymphangiomatosis, and Gorham-Stout Disease.

Authors:  Fumihiko Nakamura; Hiroki Kato; Michio Ozeki; Masayuki Matsuo
Journal:  J Clin Imaging Sci       Date:  2021-08-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.